Pasar al contenido principal

Understanding the adaptability of Smads

Images

Participantes

Contact

Imagen
Press & Communications Section Head
Tel.+34 93 40 37255

A study published in Nature Communications and led by Maria J Macias highlight new DNA motifs for the Smads proteins.

The main TGF-β signal transduction mechanism is the Smad pathway. As transcription factors, Smad proteins interact directly with DNA. However, the motif/s specifically recognized by Smads have been a matter of debate for many years. In the past, an in vitro approach identified the 5’–GTCT–3’ but its 4-base short length suggested that its presence in many Smad target genes could be random. Recent experiments in live cells have revealed that TGF-β target genes bind Smad2/3 and Smad4 complexes in promoters and enhancers lacking GTCT motifs.

A study headed by ICREA researcher Maria J Macias at the Institute for Research in Biomedicine (IRB Barcelona) has discovered a new high affinity 5-nucleotide consensus that demonstrates how Smad4, the conserved component in Smad complexes, and also Smad3 bind to these sites, providing new grounds for the understanding of cytokine-driven transcriptional control. The results indicate that the concept of Smad Binding Element needs to be revised in the literature and in textbooks, to include the new findings. The study has been published in Nature Communications in December.

Identification of the 5GC GGC(GC)|(CG) site

Using a combination of experimental techniques, the researchers identified a consensus GC-motif as the binding site of Smad4 and Smad3, and they provided 2.05 Å resolution X-ray crystal structures of the protein-DNA complexes. “Using CRISPR/Cas9, we demonstrated that binding of Smads to these sites is functional,” says Maria J. Macias. Remarkably, Smad3 and Smad4 bind to the GGC(GC)|(CG) sites reading up to five bases. The flexibility of the DNA binding hairpin characterized by NMR and SAXS, facilitates access to DNA duplexes with slightly distinct topologies and DNA sequences.

The scientists also found that the new 5GC-motifs are highly represented as clusters in Smad-bound regions genome-wide. Binding to clusters suggest how three MH1 domains in a trimeric Smad complex may bind to promoters/enhancers at once with high specificity. This capacity endows Smad transcriptional complexes with a level of adaptability that has established TGF-β as one of the most versatile and highly conserved signaling pathways in metazoans. The findings also highlight regions in promoters affected by tumour mutations, which have not been regarded as Smad targets so far.

This study was done in collaboration with the labs headed by Joan Massagué at the Memorial Sloan Kettering Cancer Center, in New York, and José A. Márquez at the European Molecular Biology Laboratory, in Grenoble.

The study was funded by the Ministry of Economy and Competitiveness, the BBVA Foundation and NIH grants. Access to the HTX facility at the EMBL (Grenoble) was supported by the Horizon 2020 Programme grant iNEXT of the European Commission. 

Article of reference:

Pau Martin-Malpartida, Marta Batet, Zuzanna Kaczmarska, Regina Freier, Tiago Gomes, Eric Aragón, Yilong Zou, Qiong Wang, Qiaoran Xi, Lidia Ruiz, Angela Vea, José A. Márquez, Joan Massagué & Maria J. Macias

Structural Basis for Genome Wide Recognition of 5-bp GC Motifs by SMAD Transcription Factors

Nature Communications (2017) doi:10.1038/s41467-017-02054-6
 

IRB Barcelona

El Instituto de Investigación Biomédica (IRB Barcelona) trabaja para conseguir una vida libre de enfermedades. Desarrolla una investigación multidisciplinar de excelencia para curar el cáncer y otras enfermedades vinculadas al envejecimiento. Establece colaboraciones con la industria farmacéutica y los principales hospitales para hacer llegar los resultados de la investigación a la sociedad, a través de la transferencia de tecnología, y realiza diferentes iniciativas de divulgación científica para mantener un diálogo abierto con la ciudadanía. El IRB Barcelona es un centro internacional que acoge alrededor de 400 científicos de más de 30 nacionalidades. Reconocido como Centro de Excelencia Severo Ochoa desde 2011, es un centro CERCA y miembro del Barcelona Institute of Science and Technology (BIST).